Literature DB >> 10526577

Anthrax toxins.

N S Duesbery1, G F Vande Woude.   

Abstract

Though its lethal effects were ascribed to an exotoxin almost half a century ago, the pathogenesis of anthrax has yet to be satisfactorily explained. Subsequent work has led to the molecular identification and enzymatic characterization of three proteins that constitute two anthrax toxins. Protective antigen binds an as yet unknown cell receptor and mediates the entry of the other two components to the cytoplasm via the endosomal pathway. Edema factor, so named for its ability to induce edema, is a Ca2+/calmodulin-dependent adenylate cyclase. Lethal factor, the dominant virulence factor associated with the toxin, proteolytically inactivates mitogen-activated protein kinase kinases, key players in signal transduction. We describe the fascinating work that has led to these discoveries and discuss their relevance to our understanding of the pathogenesis of anthrax.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10526577     DOI: 10.1007/s000180050399

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  20 in total

1.  [Anthrax. The growing danger].

Authors:  H Schorle
Journal:  Pathologe       Date:  2002-05       Impact factor: 1.011

Review 2.  Furin at the cutting edge: from protein traffic to embryogenesis and disease.

Authors:  Gary Thomas
Journal:  Nat Rev Mol Cell Biol       Date:  2002-10       Impact factor: 94.444

3.  Control of anthrax toxin gene expression by the transition state regulator abrB.

Authors:  Elke Saile; Theresa M Koehler
Journal:  J Bacteriol       Date:  2002-01       Impact factor: 3.490

4.  Neutralization of B. anthracis toxins during ex vivo phagocytosis.

Authors:  Olga Tarasenko; Ashley Scott; April Jones; Lee Soderberg; Pierre Alusta
Journal:  Glycoconj J       Date:  2012-09-15       Impact factor: 2.916

Review 5.  New developments in vaccines, inhibitors of anthrax toxins, and antibiotic therapeutics for Bacillus anthracis.

Authors:  J M Beierlein; A C Anderson
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

6.  Glycoconjugates prevent B. anthracis toxin-induced cell death through binding while activating macrophages.

Authors:  Olga Tarasenko; Ashley Scott; Lee Soderberg; Pierre Alusta
Journal:  Glycoconj J       Date:  2011-12-02       Impact factor: 2.916

7.  Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways.

Authors:  N S Duesbery; J Resau; C P Webb; S Koochekpour; H M Koo; S H Leppla; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

8.  Polymeric glycoconjugates protect and activate macrophages to promote killing of Bacillus cereus spores during phagocytosis.

Authors:  Olga Tarasenko; Elizabeth Burton; Lee Soderberg; Pierre Alusta
Journal:  Glycoconj J       Date:  2008-01-17       Impact factor: 2.916

9.  Suppression of dendritic cell activation by anthrax lethal toxin and edema toxin depends on multiple factors including cell source, stimulus used, and function tested.

Authors:  Ping-Jen Joe Chou; Catherine A Newton; Izabella Perkins; Herman Friedman; Thomas W Klein
Journal:  DNA Cell Biol       Date:  2008-12       Impact factor: 3.311

10.  The physiologic responses of Dutch belted rabbits infected with inhalational anthrax.

Authors:  William S Lawrence; Jason M Hardcastle; Douglas L Brining; Lori E Weaver; Cindy Ponce; Elbert B Whorton; Johnny W Peterson
Journal:  Comp Med       Date:  2009-06       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.